254 related articles for article (PubMed ID: 19735690)
1. Evidence for a potential role for TRPV1 receptors in the dorsolateral periaqueductal gray in the attenuation of the anxiolytic effects of cannabinoids.
Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1517-21. PubMed ID: 19735690
[TBL] [Abstract][Full Text] [Related]
2. The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors.
Batista PA; Fogaça MV; Guimarães FS
Behav Brain Res; 2015 Oct; 293():182-8. PubMed ID: 26187694
[TBL] [Abstract][Full Text] [Related]
3. Effects of glutamate NMDA and TRPV1 receptor antagonists on the biphasic responses to anandamide injected into the dorsolateral periaqueductal grey of Wistar rats.
Fogaça MV; Gomes FV; Moreira FA; Guimarães FS; Aguiar DC
Psychopharmacology (Berl); 2013 Apr; 226(3):579-87. PubMed ID: 23183551
[TBL] [Abstract][Full Text] [Related]
4. Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats.
Lisboa SF; Magesto AC; Aguiar JC; Resstel LB; Guimarães FS
Neuropharmacology; 2013 Dec; 75():86-94. PubMed ID: 23899460
[TBL] [Abstract][Full Text] [Related]
5. Differential role of CB1 and TRPV1 receptors on anandamide modulation of defensive responses induced by nitric oxide in the dorsolateral periaqueductal gray.
Lisboa SF; Guimarães FS
Neuropharmacology; 2012 Jun; 62(8):2455-62. PubMed ID: 22394688
[TBL] [Abstract][Full Text] [Related]
6. Modulation of anxiety-like behaviour by Transient Receptor Potential Vanilloid Type 1 (TRPV1) channels located in the dorsolateral periaqueductal gray.
Terzian AL; Aguiar DC; Guimarães FS; Moreira FA
Eur Neuropsychopharmacol; 2009 Mar; 19(3):188-95. PubMed ID: 19064314
[TBL] [Abstract][Full Text] [Related]
7. Modulation of defensive responses and anxiety-like behaviors by group I metabotropic glutamate receptors located in the dorsolateral periaqueductal gray.
Lima VC; Molchanov ML; Aguiar DC; Campos AC; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):178-85. PubMed ID: 17804134
[TBL] [Abstract][Full Text] [Related]
8. Anxiolytic-like effect of cannabinoids injected into the rat dorsolateral periaqueductal gray.
Moreira FA; Aguiar DC; Guimarães FS
Neuropharmacology; 2007 Mar; 52(3):958-65. PubMed ID: 17156799
[TBL] [Abstract][Full Text] [Related]
9. Activation of cannabinoid CB1 receptors in the dorsolateral periaqueductal gray induces anxiolytic effects in rats submitted to the Vogel conflict test.
Lisboa SF; Resstel LB; Aguiar DC; Guimarães FS
Eur J Pharmacol; 2008 Sep; 593(1-3):73-8. PubMed ID: 18691568
[TBL] [Abstract][Full Text] [Related]
10. Activation of CB1 cannabinoid receptors in the dorsolateral periaqueductal gray reduces the expression of contextual fear conditioning in rats.
Resstel LB; Lisboa SF; Aguiar DC; Corrêa FM; Guimarães FS
Psychopharmacology (Berl); 2008 Jun; 198(3):405-11. PubMed ID: 18446325
[TBL] [Abstract][Full Text] [Related]
11. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
12. Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats.
Aguiar DC; Terzian AL; Guimarães FS; Moreira FA
Psychopharmacology (Berl); 2009 Aug; 205(2):217-25. PubMed ID: 19387617
[TBL] [Abstract][Full Text] [Related]
13. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors.
Maione S; Bisogno T; de Novellis V; Palazzo E; Cristino L; Valenti M; Petrosino S; Guglielmotti V; Rossi F; Di Marzo V
J Pharmacol Exp Ther; 2006 Mar; 316(3):969-82. PubMed ID: 16284279
[TBL] [Abstract][Full Text] [Related]
14. Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats.
Campos AC; Guimarães FS
Psychopharmacology (Berl); 2008 Aug; 199(2):223-30. PubMed ID: 18446323
[TBL] [Abstract][Full Text] [Related]
15. Anxiogenic-like effect induced by TRPV1 receptor activation within the dorsal periaqueductal gray matter in mice.
Mascarenhas DC; Gomes KS; Nunes-de-Souza RL
Behav Brain Res; 2013 Aug; 250():308-15. PubMed ID: 23707246
[TBL] [Abstract][Full Text] [Related]
16. Antiaversive effects of cannabinoids: is the periaqueductal gray involved?
Moreira FA; Aguiar DC; Campos AC; Lisboa SF; Terzian AL; Resstel LB; Guimarães FS
Neural Plast; 2009; 2009():625469. PubMed ID: 19096514
[TBL] [Abstract][Full Text] [Related]
17. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats.
Viana TG; Hott SC; Resstel LB; Aguiar DC; Moreira FA
Psychopharmacology (Berl); 2015 May; 232(9):1545-53. PubMed ID: 25388290
[TBL] [Abstract][Full Text] [Related]
18. Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning.
Uliana DL; Hott SC; Lisboa SF; Resstel LB
Neuropharmacology; 2016 Apr; 103():257-69. PubMed ID: 26724373
[TBL] [Abstract][Full Text] [Related]
19. D-cycloserine injected into the dorsolateral periaqueductal gray induces anxiolytic-like effects in rats.
Gomes FV; Kakihata AM; Semedo AC; Hott SC; Uliana DL; Guimarães FS; Resstel LB
Behav Brain Res; 2014 Sep; 271():374-9. PubMed ID: 24931794
[TBL] [Abstract][Full Text] [Related]
20. Opposing roles for cannabinoid receptor type-1 (CB₁) and transient receptor potential vanilloid type-1 channel (TRPV1) on the modulation of panic-like responses in rats.
Casarotto PC; Terzian AL; Aguiar DC; Zangrossi H; Guimarães FS; Wotjak CT; Moreira FA
Neuropsychopharmacology; 2012 Jan; 37(2):478-86. PubMed ID: 21937980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
